Therapeutic Group

Indication Dosage

Severe Active Crohn - s Disease, Fistulating Crohn - s Disease: 

By IV Infusion: 

• Adult: Initially 5 Mg/kg, Then 5 Mg/kg After 2 Weeks, Then 5 Mg/kg After 4 Weeks, Maintenance 5 Mg/kg Every 8 Weeks According To Response 

Severe Active Ulcerative Colitis: 

By IV Infusion: 

• Adult: Initially 5 Mg/kg, Then 5 Mg/kg After 2 Weeks, Followed By 5 Mg/kg After 4 Weeks, Then 5 Mg/kg Every 8 Weeks, Discontinue If No Response 

Rheumatoid Arthritis (in Combination With Methotrexate): 

By IV Infusion: 

• Adult: Initially 3 Mg/kg, Then 3 Mg/kg After 2 Weeks, Followed By 3 Mg/kg After 4 Weeks, Then 3 Mg/kg Every 8 Weeks, If Response Is Inadequate After 12 Weeks Of Initial Treatment; Increased In Steps Of 1.5 Mg/kg Every 8 Weeks, Up To 7.5 Mg/kg Every 8 Weeks, Discontinue If No Response By 12 Weeks Of Initial Infusion 

Ankylosing Spondylitis: 

By IV Infusion: 

• Adult: 5 Mg/kg, Then 5 Mg/kg After 2 Weeks, Followed By 5 Mg/kg After 4 Weeks, Then 5 Mg/kg Every 6 - 8 Weeks, Discontinue If No Response By 6 Weeks Of Initial Infusion 

Psoriatic Arthritis (in Combination With Methotrexate), Plaque Psoriasis: 

By IV Infusion: 

• Adult: 5 Mg/kg, Then 5 Mg/kg After 2 Weeks, Followed By 5 Mg/kg After 4 Weeks, Followed By 5 Mg/kg Every 8 Weeks

Content

Pregnancy

Use Only If Essential

Stability

Contra Indications

Precautions

Lactation

Side Effects